# On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT.

> PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42233554-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42233554-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42233554-tirzepatide-v1.json
- Content SHA-256: `cb654db9ff584b98f8a4d7b41dbd3b4f6522bbae0d30be6abd58b67ac748b730`

## Claims and source pins

### Headline

On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT. ([`pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c`](#source-pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c))

### Summary

PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c`](#source-pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c))

### Paragraph 1

PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c`](#source-pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c`](#source-pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c))

## Sources

<a id="source-pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c"></a>
- **On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT. · retained source version 1:2026-06-03:current:9f27e6800a3cff36bd0e6e2547002d20b2a5a3ffd2d59a42bab4aeb1b732099b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42233554/) (`pubmed-observation-pmid-42233554-2026-06-03-9f27e6800a3c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42233554-tirzepatide-v1.json SHA-256: cb654db9ff584b98f8a4d7b41dbd3b4f6522bbae0d30be6abd58b67ac748b730.